The Austrian National Public Health Institute (Gesundheit Österreich GmbH) published a price comparison on the high-cost medicines: The study analyses Austrian prices of 80 high‐cost medicines in comparison to prices of other European Union Member States, which serve as a basis for Austrian prices that are set based on external price referencing.
The study is available in German, with an executive summary in English.
The study was peer-reviewed by researchers of the Organisation for Economic Co-operation and Development (OECD), the University of Zurich (Switzerland) and WIdO – AOK Research Institute (Germany).
For a comment of “PHARMIG – Association of the Austrian Pharmaceutical Industry” (in German) see here.
Last update: 21 October 2021